Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioharvest Sciences Inc (CSE: BHSC )

8.150 -0.150 (-1.81%)
Streaming Delayed Price Updated: 10:45 AM EDT, Aug 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,900
Open 8.300
Bid (Size) 8.170 (1,100)
Ask (Size) 8.250 (100)
Prev. Close 8.300
Today's Range 8.150 - 8.300
52wk Range 0.1600 - 9.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV)... 
Via Newsfile
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or... 
Via Newsfile

Performance

YTD
+3780.95%
+3780.95%
1 Month
-0.61%
-0.61%
3 Month
+3295.83%
+3295.83%
6 Month
+3604.55%
+3604.55%
1 Year
+4427.78%
+4427.78%

More News

Read More
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes
Via Newsfile
BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024
Via Newsfile
BioHarvest Sciences Announces Record $2 Million Monthly Sales
Via Newsfile
BioHarvest Sciences Reports First Quarter 2024 Financial Results
Via Newsfile
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time
Via Newsfile
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
Via Newsfile
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
Via Newsfile
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
Via Newsfile
Benzinga's 2024 Virtual Healthcare: What's Next In Health?
Via Benzinga
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
Via Newsfile
RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024
Via ACCESSWIRE
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
Via Newsfile
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
Via Newsfile
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
Via Newsfile
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Via Newsfile
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
Via Newsfile
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
Via Newsfile
Life Science Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th
From Virtual Investor Conferences
Via GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement
Via Newsfile
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.